Advertisement
Home » Deep Dives » CONDITION SPOTLIGHT » Condition Spotlight: Lung Cancer Biomarkers » Biomarker Testing “Essential” to Ensure Appropriate Treatment in NSCLC

Condition Spotlight: Lung Cancer Biomarker

Biomarker Testing “Essential” to Ensure Appropriate Treatment in NSCLC

Sep 14, 2023

REFERENCES & ADDITIONAL READING

Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
https://link.springer.com/article/10.1007/s40487-023-00234-7

ABOUT THE EXPERTS

  • Ernest Lo, MD

    Hematologist-Oncologist
    Senior Medical Director
    Roche Information Systems

    Ernest Lo, MD, has indicated to Physician’s Weekly that he is employed by Roche Diagnostics and holds stock in Roche.

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement